Investigational Drug Service — Atlanta, Georgia

Investigational Drug Service is a clinical research site located in Atlanta, Georgia, United States 30322.

Crixeo Health Trust Score: 64/100 (FAIR). This profile has not yet been claimed by the site owner.

Investigational Drug Service has participated in 3 clinical trials.

Therapeutic areas: Hemophilia B, Hemophilia A, Metastatic Breast Cancer.

Sponsors: Pfizer.

Sponsor Feasibility Report

Trust Score: 64/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Investigational Drug Service?

Investigational Drug Service has a Crixeo Trust Score of 64/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Investigational Drug Service conducted?

Investigational Drug Service has 3 clinical trials on record. Their work covers Hemophilia B, Hemophilia A, Metastatic Breast Cancer.

Is Investigational Drug Service accredited by Crixeo Health?

Investigational Drug Service has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Investigational Drug Service?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.